XML 13 R6.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Convertible Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning Balance at Dec. 31, 2022 $ (71,304)   $ 1 $ 40,402 $ (111,707)  
Beginning Balance, Shares at Dec. 31, 2022     84,165      
Temporary equity, Beginning balance at Dec. 31, 2022   $ 62,071        
Temporary equity, Beginning balance, Shares at Dec. 31, 2022   84,820,880        
Stock-based compensation expense 11,126     11,126    
Conversion of preferred stock to common stock as a result of the Merger, shares     2,442,852      
Conversion of preferred stock to common stock as a result of the Merger, shares   (84,820,880)        
Conversion of preferred stock to common stock as a result of the Merger, value 62,071     62,071    
Conversion of preferred stock to common stock as a result of the Merger, value   $ (62,071)        
Issuance of common stock to Graybug stockholders as a result of Merger and reset to par of $0.0001, Shares     1,571,433      
Issuance of common stock to Graybug stockholders as a result of Merger and reset to par of $0.0001 29,218     29,218    
Issuance of common shares from private placement (net of issuance costs), shares     596,363      
Issuance of common shares from private placement (net of issuance costs) 10,340     10,340    
Conversion of promissory notes into common stock, shares     590,031      
Conversion of promissory notes into common stock 3,245     3,245    
Conversion of Series C-2 Warrants into common stock, share     80,254      
Conversion of Series C-2 Warrants into common stock 442     442    
Conversion of promissory note warrants into common stock, shares     152,875      
Conversion of promissory note warrants into common stock 841     841    
Merger transaction costs (4,591)     (4,591)    
Restricted stock units net settlement (297)     (297)    
Reclassification of warrant liability to equity 216     216    
Net Income (loss) (19,288)       (19,288)  
Temporary equity, Ending balance at Mar. 31, 2023   $ 0        
Temporary equity, Ending balance, Shares at Mar. 31, 2023   0        
Ending Balance at Mar. 31, 2023 22,019   $ 1 153,013 (130,995)  
Ending Balance, Shares at Mar. 31, 2023     5,517,973      
Beginning Balance at Dec. 31, 2023 8,157   $ 1 154,218 (146,064) $ 2
Beginning Balance, Shares at Dec. 31, 2023     5,754,505      
Stock-based compensation expense 414     414    
Issuance of common stock to Graybug stockholders as a result of Merger and reset to par of $0.0001 0          
Issuance of common shares from private placement (net of issuance costs), shares     4,985,610      
Issuance of common shares from private placement (net of issuance costs) 7,905   $ 2 7,903    
Issuance of warrants in connection with the private placement 660     660    
Unrealized loss on investments (19)         (19)
Net Income (loss) 130       130  
Ending Balance at Mar. 31, 2024 $ 17,247   $ 3 $ 163,195 $ (145,934) $ (17)
Ending Balance, Shares at Mar. 31, 2024     10,740,115